Notice2022-10944
Board of Scientific Counselors, National Center for Injury Prevention and Control
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 23, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). This meeting is closed to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 99 (Monday, May 23, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31240-31241]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-10944]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control (BSC, NCIPC). This
meeting is closed to the public.
DATES: The meeting will be held on June 8, 2022, from 1 p.m. to 4 p.m.,
EDT (CLOSED).
ADDRESSES: Zoom Virtual Meeting.
FOR FURTHER INFORMATION CONTACT: Arlene Greenspan, DrPH, MPH, PT,
Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE,
Mailstop S-1069, Atlanta, Georgia 30341, Telephone: (770) 488-1279,
Email: <a href="/cdn-cgi/l/email-protection#b6d8d5dfc6d5d4c5d5f6d5d2d598d1d9c0"><span class="__cf_email__" data-cfemail="85ebe6ecf5e6e7f6e6c5e6e1e6abe2eaf3">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The meeting designated above will be closed
to the public in accordance with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. App.
2).
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, as well as
the structure, progress and performance of intramural programs. The
Board is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grant, cooperative agreement, and contract
applications received in response to funding opportunity announcements
as they relate to the Center's programmatic balance and mission; (3)
submission of secondary review recommendations to the Center Director
of applications to be considered for funding support; (4) review of
[[Page 31241]]
research portfolios, and (5) review of program proposals.
Matters to be Considered: The closed meeting will focus on the
Secondary Peer Review of extramural research grant applications
received in response to two (2) Notice of Funding Opportunities
(NOFOs): (1) RFA-CE-22-002--``Grants to Support New Investigators in
Conducting Research Related to Preventing Interpersonal Violence
Impacting Children and Youth''; (2) RFA-CE-22-004--``Research Grants to
Prevent Firearm-Related Violence and Injuries (R01)''; as well as PA-
21-259--PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for
Small Business Innovation Research (SBIR) Grant Applications (Parent
SBIR [R43/R44] Clinical Trial Not Allowed) and PA-21-260--PHS 2021-2
Omnibus Solicitation of the NIH and CDC for SBIR Grant Applications
(Parent SBIR [R43/R44] Clinical Trial Required). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-10944 Filed 5-20-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 23, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.